January 8th 2025
The FDA approved the addition of Guillain-Barré syndrome warnings for Abrysvo and Arexvy, citing postmarketing data suggesting an increased risk.
December 18th 2024
Breakthrough at ACG 2013: Oral-Only Treatment for Chronic Hepatitis C
October 17th 2013Data from pivotal international phase III clinical trials showed superior efficacy, safety, and convenience for a new wave of direct-acting oral agents. The breakthrough will benefit physicians in all practice settings, including primary care.
Fecal Microbiome Transplant in Capsule Form
October 7th 2013Clostridium difficile colitis can be cured by having patients swallow capsules brimming with other people’s concentrated stool. Inexpensive, effective, and readily available. This could be an enormous opportunity for primary care (if the FDA approves it).
Still Rx'ing Antibiotics for Bronchitis and Non–Group A Strep Sore Throat
October 7th 2013This is an opportunity for primary care to help avert a public health catastrophe. Physicians need to take ownership over this issue and demand more time for URI patients-E&M criteria do not capture what is lost when these visits are viewed simply as “Level 2 Office Visit, CPT 99212.”
Comprehensive STD Testing Improves Patient Outcomes
October 5th 2013“STD organisms are all part of an ecological pool that simply share one thing in common: sex," says the author of a new study. Testing for all important STD pathogens is the only way to detect all agents that might be involved in both symptomatic and asymptomatic patients. Details here.